Long-term follow-up of subthalamic nucleus stimulation in glucocerebrosidase-associated Parkinson's disease

Journal of Neurology

Volumn 259, Issue 9, 2012, Pages 1970-1972

  Weiss, Daniel ^a,b   Brockmann, Kathrin ^a,b   Srulijes, Karin ^a,b   Meisner, Christoph ^c   Klotz, Rosa ^a,b   Reinbold, Sophia ^a,b   Hauser, Ann Kathrin ^a,b   Schulte, Claudia ^a,b   Berg, Daniela ^a,b   Gasser, Thomas ^a,b   Plewnia, Christian ^c   Gharabaghi, Alireza ^c   Breit, Sorin ^a,b   Wächter, Tobias ^a,b   Krüger, Rejko ^a,b  

^a GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDASE; LEVODOPA;

BRAIN DEPTH STIMULATION; CLINICAL FEATURE; DEMENTIA; FOLLOW UP; GAIT; GENE MUTATION; GENOTYPE; HUMAN; LETTER; LEWY BODY; NERVE DEGENERATION; PARKINSON DISEASE; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS;

ADULT; DNA MUTATIONAL ANALYSIS; ELECTRIC STIMULATION THERAPY; FEMALE; GLUCOSYLCERAMIDASE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; MUTATION; PARKINSON DISEASE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SUBTHALAMIC NUCLEUS;

EID: 84867303390     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6469-7     Document Type: Letter

References (11)

1. Clark LN, Kartsaklis LA, Wolf Gilbert R, Dorado B, Ross BM, Kisseley S, Verbitsky M, Mejia-Santana H, Cote LJ, Andrews H, Vonsattel JP, Fahn S, Mayeux R, Honig LS, Marder K (2009) Association of glucocerebrosidase mutations with dementia with Lewy bodies. Arch Neurol 66:578-583
2. Sidransky E, Nalls MA, Aasly JO et al (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med 361:1651-1661
3. Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E (2008) The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol 65:1353-1357
4. Neumann J, Bras J, Deas E, O'Sullivan SS, Parkkinen L, Lachmann RH, Li A, Holton J, Guerreiro R, Paudel R, Segarane B, Singleton A, Lees A, Hardy J, Houlden H, Revesz T, Wood NW (2009) Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain 132:1783-1794
5. Gan-Or Z, Giladi N, Orr-Urtreger A (2009) Differential phenotype in Parkinson's disease patients with severe versus mild GBA mutations. Brain 132:e125
6. Brockmann K, Srulijes K, Hauser AK, Schulte C, Csoti I, Gasser T, Berg D (2011) GBA-associated PD presents with nonmotor characteristics. Neurology 77:276-280
7. Giladi N, Tal J, Azulay T, Rascol O, Brooks DJ, Melamed E, Oertel W, Poewe WH, Stocchi F, Tolosa E (2009) Validation of the freezing of gait questionnaire in patients with Parkinson's disease. Mov Disord 24:655-661
8. Storch A, Odin P, Trender-Gerhard I, Fuchs G, Reifschneider G, Ray Chaudhuri K, Jost WH, Ebersbach G (2010) Non-motor Symptoms Questionnaire and Scale for Parkinson's disease. Cross-cultural adaptation into the German language. Nervenarzt 81:980-985
9. Levy G, Tang MX, Cote LJ, Louis ED, Alfaro B, Mejia H, Stern Y, Marder K (2000) Motor impairment in PD: relationship to incident dementia and age. Neurology 55:539-544
10. Hamani C, Moro E, Lozano AM (2011) The pedunculopontine nucleus as a target for deep brain stimulation. J Neural Transm 118(10):1461-1468
11. Weiss D, Wächter T, Meisner C, Fritz M, Gharabaghi A, Plewnia C, Breit S, Krüger R (2011) Combined STN/SNr-DBS for the treatment of refractory gait disturbances in Parkinson's disease: study protocol for a randomized controlled trial. Trials 12:222